文献速递泌尿生殖腹部MR

定量多参数MRI预测膀胱癌新辅助化疗早期反应的前瞻性研究

Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer.
PubMed 文献 · Eur J Radiol · 2022-11-01

该前瞻性试点研究纳入24例肌层浸润性膀胱癌患者,在新辅助化疗前、首次顺铂给药后24小时及化疗后行时序MRI,定量分析Ktrans、Vp、Ve及ADC。结果显示定量MRI参数可预测病理反应,基于化疗前与24小时MRI构建的qRECIST模型AUC达0.91,有望用于筛选NAC获益人群。

要点

  • 化疗前ADC_M(AUC=0.859)与ADC指数(AUC=0.844)可预测NAC反应。
  • 首次顺铂后24小时ADC_M同样具有预测价值(AUC=0.816)。
  • 基于化疗前与24小时MRI的qRECIST模型AUC=0.91,准确率0.75。

核心结论

  • mpMRI参数对NAC反应具有优秀诊断效能,qRECIST可在化疗早期预测MIBC对NAC的敏感性并辅助候选患者筛选。

研究设计与样本

  • 前瞻性试点研究,共纳入24例肌层浸润性膀胱癌患者,接受NAC前、首次顺铂给药后24小时及NAC后三个时间点MRI。
  • 采用动态对比增强与扩散加权成像定量Ktrans、Vp、Ve及ADC,以病理反应为参考标准评估化疗敏感性。

诊断标准与关键数值

  • 化疗前ADC_M预测NAC反应AUC=0.859(P=0.005),ADC指数AUC=0.844(P=0.007)。
  • 24小时NAC时间点ADC_M预测反应AUC=0.816(P=0.013)。
  • qRECIST模型预测NAC敏感性AUC=0.91,真阳性率0.8,准确率0.75。

临床应用与阅片要点

  • 可关注化疗前ADC_M及ADC指数作为潜在预测指标,但需注意本研究为小样本试点,尚未确立临床阈值。
  • 首次顺铂后24小时ADC_M变化可能提供早期反应信息,qRECIST模型整合化疗前与24小时MRI指标。

局限性

  • 本研究为试点研究,样本量仅24例,其中病理确认NAC反应者8例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Magnetic resonance imaging (MRI) has been applied to predict the neoadjuvant chemotherapy (NAC) response of bladder cancer at an early stage, but the performance remains poor. A tool for the selection of patients with muscle-invasive bladder cancer (MIBC) with high probability of benefitting from NAC is not yet available. We designed a prospective study to assess a quantitative MRI for predicting the early response of MIBC to NAC.

METHODS: All individuals underwent a time-course MRI at pre-NAC, 24 h after initial cisplatin medication (24 h-NAC) and post-NAC.Chemosensitivity was evaluated according to pathological response.The transfer constant (Ktrans), plasma volume (Vp), extravascular extracellular space (Ve), and apparent diffusion coefficient (ADC) were quantitated based on dynamic contrast-enhanced and diffusion-weighted imaging.Quantitative RECIST criteria were constructed by modelling pre-NAC and 24 h-NAC MRI measures, and then compared with conventional RECIST by using pre- and post-NAC MRI measures.

RESULTS: In this pilot study, a total of 24 patients were enrolled into the study. Eight patients were pathologically confirmed to be NAC-responders. After a thorough evaluation of these parameters, different parameters showed good discrimination at different point in time. ROC curves showed quantitative MRI can predict the response to NAC, especially ADC_M (AUC = 0.859, P = 0.005) and ADC index (AUC = 0.844, P = 0.007) at pre-NAC timing and ADC_M (AUC = 0.816, P = 0.013) at 24 h-NAC timing. Then, a qRECIST model was established for predicting NAC sensitivity, with AUC of 0.91, TP rate of 0.8, and accuracy of 0.75.

CONCLUSION: The diagnostic performance of mpMRI parameters for NAC response is excellent. The qRECIST derived between pre- and 24 h NAC MRI could predict the early response of MIBC to NAC and help for candidate selection.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang, Yuan, Zhang, et al. Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer. Eur J Radiol. 2022. PMID: 36345088. doi:10.1016/j.ejrad.2022.110587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。